Acumen Pharmaceuticals Lands Series A Financing

  • Feed Type
  • Date
    4/27/2013
  • Company Name
    Acumen Pharmaceuticals
  • Mailing Address
    4435 North First Street Livermore, CA 94551
  • Company Description
    Acumen Pharmaceuticals, Inc. is a biotechnology company developing disease modifying medicines and diagnostics for Alzheimer’s disease. Acumen Pharmaceuticals Inc. is engaged in the discovery and development of therapeutics and diagnostics related to soluble Aß oligomers in Alzheimer’s disease.
  • Website
    http://www.acumenpharm.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    Undisclosed
  • Transaction Round
    Series A
  • Proceeds Purposes
    The capital will fund preclinical and potentially early clinical development of ACU-193, which selectively binds to and captures soluble oligomers of the amyloid-beta peptide.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.